CA2529239C - Non-invasive acupuncture device - Google Patents

Non-invasive acupuncture device Download PDF

Info

Publication number: CA2529239C
Authority: CA; Canada
Prior art keywords: patients; group; effectiveness; treatment; tourmaline
Prior art date: 2005-11-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA2529239A

Other languages

English (en)

French (fr)

Other versions

CA2529239A1 (en

Inventor

Mengjun Yang

Zhilong Xu

Ping Li

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-03

Filing date

2005-11-23

Publication date

2011-03-08

2005-11-23 Application filed by Individual filed Critical Individual

2006-03-16 Priority to AT06705333T priority Critical patent/ATE537805T1/de

2006-03-16 Priority to JP2008538231A priority patent/JP5015165B2/ja

2006-03-16 Priority to KR1020087010112A priority patent/KR100961595B1/ko

2006-03-16 Priority to EP06705333A priority patent/EP1945171B1/de

2006-03-16 Priority to PCT/CA2006/000392 priority patent/WO2007051278A1/en

2006-03-17 Priority to US11/377,858 priority patent/US8936815B2/en

2007-05-03 Publication of CA2529239A1 publication Critical patent/CA2529239A1/en

2011-03-08 Application granted granted Critical

2011-03-08 Publication of CA2529239C publication Critical patent/CA2529239C/en

2025-11-23 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000001467 acupuncture Methods 0.000 title claims abstract description 83
239000000203 mixture Substances 0.000 claims abstract description 9
239000007787 solid Substances 0.000 claims abstract description 6
239000000463 material Substances 0.000 claims description 28
229910052613 tourmaline Inorganic materials 0.000 claims description 21
239000011032 tourmaline Substances 0.000 claims description 21
229940070527 tourmaline Drugs 0.000 claims description 21
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
150000001875 compounds Chemical class 0.000 claims description 8
239000002131 composite material Substances 0.000 claims description 7
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 6
239000000853 adhesive Substances 0.000 claims description 6
230000001070 adhesive effect Effects 0.000 claims description 6
JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 6
229910052742 iron Inorganic materials 0.000 claims description 6
UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 6
229910052749 magnesium Inorganic materials 0.000 claims description 6
239000011777 magnesium Substances 0.000 claims description 6
230000001699 photocatalysis Effects 0.000 claims description 6
229920000915 polyvinyl chloride Polymers 0.000 claims description 6
239000004800 polyvinyl chloride Substances 0.000 claims description 6
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 5
XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 5
BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 5
239000000292 calcium oxide Substances 0.000 claims description 5
ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 5
CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 5
239000000696 magnetic material Substances 0.000 claims description 5
239000000843 powder Substances 0.000 claims description 5
150000003839 salts Chemical class 0.000 claims description 5
239000000395 magnesium oxide Substances 0.000 claims description 4
241000414967 Colophon Species 0.000 claims description 3
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
235000011613 Pinus brutia Nutrition 0.000 claims description 3
241000018646 Pinus brutia Species 0.000 claims description 3
235000021355 Stearic acid Nutrition 0.000 claims description 3
CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 claims description 3
229910000421 cerium(III) oxide Inorganic materials 0.000 claims description 3
229910000422 cerium(IV) oxide Inorganic materials 0.000 claims description 3
MRELNEQAGSRDBK-UHFFFAOYSA-N lanthanum oxide Inorganic materials [O-2].[O-2].[O-2].[La+3].[La+3] MRELNEQAGSRDBK-UHFFFAOYSA-N 0.000 claims description 3
239000000944 linseed oil Substances 0.000 claims description 3
235000021388 linseed oil Nutrition 0.000 claims description 3
229940057995 liquid paraffin Drugs 0.000 claims description 3
229910052744 lithium Inorganic materials 0.000 claims description 3
AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 3
PLDDOISOJJCEMH-UHFFFAOYSA-N neodymium oxide Inorganic materials [O-2].[O-2].[O-2].[Nd+3].[Nd+3] PLDDOISOJJCEMH-UHFFFAOYSA-N 0.000 claims description 3
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
239000011347 resin Substances 0.000 claims description 3
229920005989 resin Polymers 0.000 claims description 3
239000008117 stearic acid Substances 0.000 claims description 3
229910001477 LaPO4 Inorganic materials 0.000 claims description 2
239000004359 castor oil Substances 0.000 claims description 2
235000019438 castor oil Nutrition 0.000 claims description 2
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
229920000609 methyl cellulose Polymers 0.000 claims description 2
239000001923 methylcellulose Substances 0.000 claims description 2
235000010981 methylcellulose Nutrition 0.000 claims description 2
QGLKJKCYBOYXKC-UHFFFAOYSA-N nonaoxidotritungsten Chemical compound O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1 QGLKJKCYBOYXKC-UHFFFAOYSA-N 0.000 claims description 2
239000010980 sapphire Substances 0.000 claims description 2
229910052594 sapphire Inorganic materials 0.000 claims description 2
XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 claims description 2
229910001887 tin oxide Inorganic materials 0.000 claims description 2
229910001930 tungsten oxide Inorganic materials 0.000 claims description 2
KTUFCUMIWABKDW-UHFFFAOYSA-N oxo(oxolanthaniooxy)lanthanum Chemical compound O=[La]O[La]=O KTUFCUMIWABKDW-UHFFFAOYSA-N 0.000 claims 2
239000012188 paraffin wax Substances 0.000 claims 2
239000011787 zinc oxide Substances 0.000 claims 2
239000013078 crystal Substances 0.000 claims 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
239000003921 oil Substances 0.000 claims 1
235000019198 oils Nutrition 0.000 claims 1
QHGNHLZPVBIIPX-UHFFFAOYSA-N tin(II) oxide Inorganic materials [Sn]=O QHGNHLZPVBIIPX-UHFFFAOYSA-N 0.000 claims 1
238000011282 treatment Methods 0.000 abstract description 94
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 47
201000010099 disease Diseases 0.000 abstract description 44
239000003814 drug Substances 0.000 abstract description 38
230000001225 therapeutic effect Effects 0.000 abstract description 34
229940079593 drug Drugs 0.000 abstract description 31
230000001684 chronic effect Effects 0.000 abstract description 10
230000005611 electricity Effects 0.000 abstract description 6
230000005855 radiation Effects 0.000 abstract description 3
208000024891 symptom Diseases 0.000 description 45
230000000694 effects Effects 0.000 description 38
238000002560 therapeutic procedure Methods 0.000 description 38
208000002193 Pain Diseases 0.000 description 28
206010020772 Hypertension Diseases 0.000 description 14
230000007812 deficiency Effects 0.000 description 12
208000017667 Chronic Disease Diseases 0.000 description 11
206010019233 Headaches Diseases 0.000 description 9
210000004369 blood Anatomy 0.000 description 9
239000008280 blood Substances 0.000 description 9
231100000869 headache Toxicity 0.000 description 9
238000002483 medication Methods 0.000 description 9
238000000034 method Methods 0.000 description 9
208000025865 Ulcer Diseases 0.000 description 8
231100000397 ulcer Toxicity 0.000 description 8
230000003902 lesion Effects 0.000 description 7
102000004169 proteins and genes Human genes 0.000 description 7
108090000623 proteins and genes Proteins 0.000 description 7
210000002700 urine Anatomy 0.000 description 7
208000002173 dizziness Diseases 0.000 description 6
210000000265 leukocyte Anatomy 0.000 description 6
230000033001 locomotion Effects 0.000 description 6
210000004379 membrane Anatomy 0.000 description 6
239000012528 membrane Substances 0.000 description 6
210000000952 spleen Anatomy 0.000 description 6
206010010774 Constipation Diseases 0.000 description 5
206010062717 Increased upper airway secretion Diseases 0.000 description 5
230000036772 blood pressure Effects 0.000 description 5
239000012530 fluid Substances 0.000 description 5
230000000474 nursing effect Effects 0.000 description 5
208000026435 phlegm Diseases 0.000 description 5
230000008569 process Effects 0.000 description 5
210000001835 viscera Anatomy 0.000 description 5
206010002383 Angina Pectoris Diseases 0.000 description 4
206010006458 Bronchitis chronic Diseases 0.000 description 4
201000004624 Dermatitis Diseases 0.000 description 4
208000004232 Enteritis Diseases 0.000 description 4
206010030113 Oedema Diseases 0.000 description 4
208000000418 Premature Cardiac Complexes Diseases 0.000 description 4
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
208000007107 Stomach Ulcer Diseases 0.000 description 4
208000006011 Stroke Diseases 0.000 description 4
230000002411 adverse Effects 0.000 description 4
230000002146 bilateral effect Effects 0.000 description 4
206010006451 bronchitis Diseases 0.000 description 4
229960000623 carbamazepine Drugs 0.000 description 4
FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 4
208000007451 chronic bronchitis Diseases 0.000 description 4
230000002708 enhancing effect Effects 0.000 description 4
201000005917 gastric ulcer Diseases 0.000 description 4
210000003128 head Anatomy 0.000 description 4
230000036541 health Effects 0.000 description 4
229910052500 inorganic mineral Inorganic materials 0.000 description 4
206010022437 insomnia Diseases 0.000 description 4
208000002551 irritable bowel syndrome Diseases 0.000 description 4
230000027939 micturition Effects 0.000 description 4
239000011707 mineral Substances 0.000 description 4
208000011580 syndromic disease Diseases 0.000 description 4
244000052909 Dioscorea esculenta Species 0.000 description 3
201000005569 Gout Diseases 0.000 description 3
208000036826 VIIth nerve paralysis Diseases 0.000 description 3
230000001154 acute effect Effects 0.000 description 3
206010003246 arthritis Diseases 0.000 description 3
208000006673 asthma Diseases 0.000 description 3
208000010668 atopic eczema Diseases 0.000 description 3
230000000295 complement effect Effects 0.000 description 3
208000029078 coronary artery disease Diseases 0.000 description 3
208000000718 duodenal ulcer Diseases 0.000 description 3
230000001815 facial effect Effects 0.000 description 3
206010016256 fatigue Diseases 0.000 description 3
238000002575 gastroscopy Methods 0.000 description 3
238000000227 grinding Methods 0.000 description 3
206010020718 hyperplasia Diseases 0.000 description 3
230000006872 improvement Effects 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
210000003734 kidney Anatomy 0.000 description 3
238000005259 measurement Methods 0.000 description 3
238000000386 microscopy Methods 0.000 description 3
238000002156 mixing Methods 0.000 description 3
230000001575 pathological effect Effects 0.000 description 3
150000002910 rare earth metals Chemical class 0.000 description 3
230000035807 sensation Effects 0.000 description 3
235000019615 sensations Nutrition 0.000 description 3
230000000391 smoking effect Effects 0.000 description 3
238000007669 thermal treatment Methods 0.000 description 3
208000004371 toothache Diseases 0.000 description 3
231100000331 toxic Toxicity 0.000 description 3
230000002588 toxic effect Effects 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
208000004998 Abdominal Pain Diseases 0.000 description 2
241001421185 Anomis Species 0.000 description 2
208000008035 Back Pain Diseases 0.000 description 2
206010008190 Cerebrovascular accident Diseases 0.000 description 2
206010008642 Cholesteatoma Diseases 0.000 description 2
206010010904 Convulsion Diseases 0.000 description 2
229920000742 Cotton Polymers 0.000 description 2
208000004929 Facial Paralysis Diseases 0.000 description 2
208000005577 Gastroenteritis Diseases 0.000 description 2
206010060891 General symptom Diseases 0.000 description 2
206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
206010024453 Ligament sprain Diseases 0.000 description 2
208000027530 Meniere disease Diseases 0.000 description 2
206010028980 Neoplasm Diseases 0.000 description 2
206010029164 Nephrotic syndrome Diseases 0.000 description 2
206010033557 Palpitations Diseases 0.000 description 2
241000549096 Paxistima canbyi Species 0.000 description 2
206010034464 Periarthritis Diseases 0.000 description 2
206010067171 Regurgitation Diseases 0.000 description 2
206010040639 Sick sinus syndrome Diseases 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000009471 action Effects 0.000 description 2
208000012873 acute gastroenteritis Diseases 0.000 description 2
239000002390 adhesive tape Substances 0.000 description 2
230000004075 alteration Effects 0.000 description 2
229940126675 alternative medicines Drugs 0.000 description 2
230000001088 anti-asthma Effects 0.000 description 2
239000000924 antiasthmatic agent Substances 0.000 description 2
206010003119 arrhythmia Diseases 0.000 description 2
206010003549 asthenia Diseases 0.000 description 2
229940127225 asthma medication Drugs 0.000 description 2
229910052788 barium Inorganic materials 0.000 description 2
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
238000001574 biopsy Methods 0.000 description 2
210000000621 bronchi Anatomy 0.000 description 2
206010061592 cardiac fibrillation Diseases 0.000 description 2
238000002512 chemotherapy Methods 0.000 description 2
210000000038 chest Anatomy 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
208000021735 chronic enteritis Diseases 0.000 description 2
208000013507 chronic prostatitis Diseases 0.000 description 2
238000002052 colonoscopy Methods 0.000 description 2
229940126676 complementary medicines Drugs 0.000 description 2
230000036461 convulsion Effects 0.000 description 2
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
210000003608 fece Anatomy 0.000 description 2
230000002600 fibrillogenic effect Effects 0.000 description 2
206010016766 flatulence Diseases 0.000 description 2
230000006870 function Effects 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
210000002837 heart atrium Anatomy 0.000 description 2
230000004217 heart function Effects 0.000 description 2
208000035861 hematochezia Diseases 0.000 description 2
208000000509 infertility Diseases 0.000 description 2
230000036512 infertility Effects 0.000 description 2
231100000535 infertility Toxicity 0.000 description 2
230000003907 kidney function Effects 0.000 description 2
230000007774 longterm Effects 0.000 description 2
230000005389 magnetism Effects 0.000 description 2
239000002075 main ingredient Substances 0.000 description 2
235000012054 meals Nutrition 0.000 description 2
208000010125 myocardial infarction Diseases 0.000 description 2
208000009928 nephrosis Diseases 0.000 description 2
231100001027 nephrosis Toxicity 0.000 description 2
239000002245 particle Substances 0.000 description 2
210000003516 pericardium Anatomy 0.000 description 2
238000012545 processing Methods 0.000 description 2
210000002307 prostate Anatomy 0.000 description 2
210000004908 prostatic fluid Anatomy 0.000 description 2
201000007094 prostatitis Diseases 0.000 description 2
201000001474 proteinuria Diseases 0.000 description 2
229910052761 rare earth metal Inorganic materials 0.000 description 2
210000002345 respiratory system Anatomy 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
206010044652 trigeminal neuralgia Diseases 0.000 description 2
230000002861 ventricular Effects 0.000 description 2
108700005239 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Proteins 0.000 description 1
206010000087 Abdominal pain upper Diseases 0.000 description 1
206010000097 Abdominal tenderness Diseases 0.000 description 1
208000002874 Acne Vulgaris Diseases 0.000 description 1
208000007848 Alcoholism Diseases 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
208000019901 Anxiety disease Diseases 0.000 description 1
206010003210 Arteriosclerosis Diseases 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
208000006373 Bell palsy Diseases 0.000 description 1
206010005963 Bone formation increased Diseases 0.000 description 1
208000014644 Brain disease Diseases 0.000 description 1
235000002568 Capsicum frutescens Nutrition 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
208000002177 Cataract Diseases 0.000 description 1
206010008088 Cerebral artery embolism Diseases 0.000 description 1
206010008479 Chest Pain Diseases 0.000 description 1
JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
206010008617 Cholecystitis chronic Diseases 0.000 description 1
206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
206010008909 Chronic Hepatitis Diseases 0.000 description 1
206010009152 Chronic tonsillitis Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
206010011730 Cylindruria Diseases 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
206010012289 Dementia Diseases 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
208000003556 Dry Eye Syndromes Diseases 0.000 description 1
206010013774 Dry eye Diseases 0.000 description 1
208000005171 Dysmenorrhea Diseases 0.000 description 1
206010013935 Dysmenorrhoea Diseases 0.000 description 1
208000000059 Dyspnea Diseases 0.000 description 1
206010013975 Dyspnoeas Diseases 0.000 description 1
208000005189 Embolism Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
206010014561 Emphysema Diseases 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
208000004930 Fatty Liver Diseases 0.000 description 1
208000007882 Gastritis Diseases 0.000 description 1
208000010412 Glaucoma Diseases 0.000 description 1
206010018634 Gouty Arthritis Diseases 0.000 description 1
206010019468 Hemiplegia Diseases 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
206010019708 Hepatic steatosis Diseases 0.000 description 1
208000007514 Herpes zoster Diseases 0.000 description 1
208000031226 Hyperlipidaemia Diseases 0.000 description 1
206010020675 Hypermetropia Diseases 0.000 description 1
206010051151 Hyperviscosity syndrome Diseases 0.000 description 1
208000034767 Hypoproteinaemia Diseases 0.000 description 1
208000004356 Hysteria Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
206010049949 Intercostal neuralgia Diseases 0.000 description 1
208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
239000009220 Liuwei Dihuang Decoction Substances 0.000 description 1
208000002720 Malnutrition Diseases 0.000 description 1
208000037093 Menstruation Disturbances Diseases 0.000 description 1
206010028836 Neck pain Diseases 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000007443 Neurasthenia Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
206010059013 Nocturnal emission Diseases 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
208000018737 Parkinson disease Diseases 0.000 description 1
208000008469 Peptic Ulcer Diseases 0.000 description 1
201000007100 Pharyngitis Diseases 0.000 description 1
206010035148 Plague Diseases 0.000 description 1
206010036790 Productive cough Diseases 0.000 description 1
206010051482 Prostatomegaly Diseases 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
206010039085 Rhinitis allergic Diseases 0.000 description 1
240000007164 Salvia officinalis Species 0.000 description 1
208000008765 Sciatica Diseases 0.000 description 1
206010039966 Senile dementia Diseases 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
208000032023 Signs and Symptoms Diseases 0.000 description 1
208000007718 Stable Angina Diseases 0.000 description 1
208000009205 Tinnitus Diseases 0.000 description 1
208000030886 Traumatic Brain injury Diseases 0.000 description 1
208000007814 Unstable Angina Diseases 0.000 description 1
208000024780 Urticaria Diseases 0.000 description 1
208000001407 Vascular Headaches Diseases 0.000 description 1
206010047115 Vasculitis Diseases 0.000 description 1
208000012886 Vertigo Diseases 0.000 description 1
241000700605 Viruses Species 0.000 description 1
206010047531 Visual acuity reduced Diseases 0.000 description 1
206010047924 Wheezing Diseases 0.000 description 1
241000607479 Yersinia pestis Species 0.000 description 1
208000031971 Yin Deficiency Diseases 0.000 description 1
PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
210000001015 abdomen Anatomy 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
206010000496 acne Diseases 0.000 description 1
208000012876 acute enteritis Diseases 0.000 description 1
238000005054 agglomeration Methods 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004378 air conditioning Methods 0.000 description 1
201000010105 allergic rhinitis Diseases 0.000 description 1
230000036506 anxiety Effects 0.000 description 1
230000006793 arrhythmia Effects 0.000 description 1
208000011775 arteriosclerosis disease Diseases 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
235000019658 bitter taste Nutrition 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
210000001772 blood platelet Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
229960000830 captopril Drugs 0.000 description 1
FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
230000002490 cerebral effect Effects 0.000 description 1
HSJPMRKMPBAUAU-UHFFFAOYSA-N cerium nitrate Inorganic materials [Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O HSJPMRKMPBAUAU-UHFFFAOYSA-N 0.000 description 1
230000008859 change Effects 0.000 description 1
201000001352 cholecystitis Diseases 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
208000023652 chronic gastritis Diseases 0.000 description 1
201000009151 chronic rhinitis Diseases 0.000 description 1
238000009535 clinical urine test Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
208000012839 conversion disease Diseases 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
238000009223 counseling Methods 0.000 description 1
229940109239 creatinine Drugs 0.000 description 1
231100000895 deafness Toxicity 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
230000001079 digestive effect Effects 0.000 description 1
208000010643 digestive system disease Diseases 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
238000001827 electrotherapy Methods 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
208000030172 endocrine system disease Diseases 0.000 description 1
206010015037 epilepsy Diseases 0.000 description 1
238000004880 explosion Methods 0.000 description 1
208000014337 facial nerve disease Diseases 0.000 description 1
201000005577 familial hyperlipidemia Diseases 0.000 description 1
208000010706 fatty liver disease Diseases 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
235000021197 fiber intake Nutrition 0.000 description 1
208000001130 gallstones Diseases 0.000 description 1
208000016354 hearing loss disease Diseases 0.000 description 1
208000006750 hematuria Diseases 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
241000411851 herbal medicine Species 0.000 description 1
230000004305 hyperopia Effects 0.000 description 1
201000006318 hyperopia Diseases 0.000 description 1
230000036039 immunity Effects 0.000 description 1
201000001881 impotence Diseases 0.000 description 1
201000001371 inclusion conjunctivitis Diseases 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
201000010849 intracranial embolism Diseases 0.000 description 1
239000010977 jade Substances 0.000 description 1
238000011862 kidney biopsy Methods 0.000 description 1
201000006370 kidney failure Diseases 0.000 description 1
238000009533 lab test Methods 0.000 description 1
238000002647 laser therapy Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
238000002653 magnetic therapy Methods 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
206010025482 malaise Diseases 0.000 description 1
230000001071 malnutrition Effects 0.000 description 1
235000000824 malnutrition Nutrition 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000013160 medical therapy Methods 0.000 description 1
230000009245 menopause Effects 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
230000036651 mood Effects 0.000 description 1
238000000465 moulding Methods 0.000 description 1
230000003387 muscular Effects 0.000 description 1
208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
208000001491 myopia Diseases 0.000 description 1
230000004379 myopia Effects 0.000 description 1
201000008383 nephritis Diseases 0.000 description 1
208000004296 neuralgia Diseases 0.000 description 1
208000009157 neurocirculatory asthenia Diseases 0.000 description 1
230000000926 neurological effect Effects 0.000 description 1
208000015380 nutritional deficiency disease Diseases 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
230000000399 orthopedic effect Effects 0.000 description 1
231100000915 pathological change Toxicity 0.000 description 1
230000036285 pathological change Effects 0.000 description 1
208000011906 peptic ulcer disease Diseases 0.000 description 1
210000002640 perineum Anatomy 0.000 description 1
238000000554 physical therapy Methods 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000011505 plaster Substances 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000003825 pressing Methods 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
208000020016 psychiatric disease Diseases 0.000 description 1
238000010298 pulverizing process Methods 0.000 description 1
229910001404 rare earth metal oxide Inorganic materials 0.000 description 1
235000005412 red sage Nutrition 0.000 description 1
208000023504 respiratory system disease Diseases 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
206010039083 rhinitis Diseases 0.000 description 1
RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 1
238000009666 routine test Methods 0.000 description 1
238000007790 scraping Methods 0.000 description 1
230000037307 sensitive skin Effects 0.000 description 1
208000012201 sexual and gender identity disease Diseases 0.000 description 1
208000015891 sexual disease Diseases 0.000 description 1
208000013220 shortness of breath Diseases 0.000 description 1
201000009890 sinusitis Diseases 0.000 description 1
201000005671 spondyloarthropathy Diseases 0.000 description 1
208000024794 sputum Diseases 0.000 description 1
210000003802 sputum Anatomy 0.000 description 1
231100000240 steatosis hepatitis Toxicity 0.000 description 1
238000002563 stool test Methods 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1
230000008961 swelling Effects 0.000 description 1
231100000886 tinnitus Toxicity 0.000 description 1
230000003867 tiredness Effects 0.000 description 1
208000016255 tiredness Diseases 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
206010044008 tonsillitis Diseases 0.000 description 1
206010044325 trachoma Diseases 0.000 description 1
238000002834 transmittance Methods 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
208000014001 urinary system disease Diseases 0.000 description 1
208000019206 urinary tract infection Diseases 0.000 description 1
231100000889 vertigo Toxicity 0.000 description 1
229940087652 vioxx Drugs 0.000 description 1
239000002699 waste material Substances 0.000 description 1
239000001993 wax Substances 0.000 description 1
239000010154 weishu Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/04—Devices for pressing such points, e.g. Shiatsu or Acupressure
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/16—Physical interface with patient
- A61H2201/1683—Surface of interface
- A61H2201/169—Physical characteristics of the surface, e.g. material, relief, texture or indicia

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Rehabilitation Therapy (AREA)
Nanotechnology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Condensed Matter Physics & Semiconductors (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Physics & Mathematics (AREA)
Physical Education & Sports Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Physics & Mathematics (AREA)
Manufacturing & Machinery (AREA)
Pain & Pain Management (AREA)
Crystallography & Structural Chemistry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Finger-Pressure Massage (AREA)
Radiation-Therapy Devices (AREA)

CA2529239A 2005-11-03 2005-11-23 Non-invasive acupuncture device Expired - Fee Related CA2529239C (en)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
AT06705333T ATE537805T1 (de)	2005-11-03	2006-03-16	Herstellung und verwendung eines medizinprodukts in der alternativen medizin zur rehabilitationsbehandlung bei chronischen ekrankungen
JP2008538231A JP5015165B2 (ja)	2005-11-03	2006-03-16	代替え療法における慢性疾患リハビリテーション治療用医療器具の製造と使用
KR1020087010112A KR100961595B1 (ko)	2005-11-03	2006-03-16	대체의학적 치료용 칩 및 그 제조방법
EP06705333A EP1945171B1 (de)	2005-11-03	2006-03-16	Herstellung und verwendung eines medizinprodukts in der alternativen medizin zur rehabilitationsbehandlung bei chronischen ekrankungen
PCT/CA2006/000392 WO2007051278A1 (en)	2005-11-03	2006-03-16	A medical device's manufacture and usage in alternative medicine for rehabilitation treatment of chronic diseases
US11/377,858 US8936815B2 (en)	2005-11-03	2006-03-17	Device for external use in alternative medicine applications

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CN200510117269.9		2005-11-03
CN2005101172699A CN1957946B (zh)	2005-11-03	2005-11-03	一种慢性病康复芯片的制作方法和所制作康复芯片及用途

Publications (2)

Publication Number	Publication Date
CA2529239A1 CA2529239A1 (en)	2007-05-03
CA2529239C true CA2529239C (en)	2011-03-08

Family

ID=38051246

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2529239A Expired - Fee Related CA2529239C (en)	2005-11-03	2005-11-23	Non-invasive acupuncture device

Country Status (5)

Country	Link
JP (1)	JP5015165B2 (de)
KR (1)	KR100961595B1 (de)
CN (1)	CN1957946B (de)
AT (1)	ATE537805T1 (de)
CA (1)	CA2529239C (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103316014A (zh) *	2008-08-13	2013-09-25	杨孟君	特异性针灸功能复合材料及其制备方法与用途
CN105434110A (zh) *	2014-09-28	2016-03-30	李湘	一种磁脉通女士卫生护理巾贴
CN105381509A (zh) *	2015-11-24	2016-03-09	林子莉	一种拔罐丰胸的方法
CN109646293A (zh) *	2017-10-12	2019-04-19	杨孟君	顺势针灸器具
CN111096902A (zh) *	2018-10-26	2020-05-05	杨孟君	定向磁化机
CN111840295A (zh) *	2020-08-18	2020-10-30	隆琰	失眠治疗药物、制备方法及其在治疗失眠症上的应用
CN112274423B (zh) *	2020-11-11	2023-05-12	山东泰山本草科技开发有限公司	药用艾条、使用方法、悬灸筒及其用途
CN113941096A (zh) *	2021-10-14	2022-01-18	陈夏滨	一种能量芯片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2000007470A (ja)	1998-06-19	2000-01-11	Sanshin Sangyo Kk	放射線発生セラミックスおよびその製造方法
JP2001149489A (ja)	1999-11-29	2001-06-05	Tokin Corp	ポリマー複合健康器具
JP2001161831A (ja) *	1999-12-08	2001-06-19	Nikko Seiki Kk	遠赤外線磁気治療器
JP2001353227A (ja) *	2000-06-16	2001-12-25	Sanei Kasei Kk	磁気治療器
WO2004025006A1 (en)	2002-07-23	2004-03-25	Jung Suk Lee	A method of preparing a body-stimulating synthetic resin
CN1502326A (zh) *	2002-11-27	2004-06-09	鲁景远	肛门栓
JP2004188397A (ja)	2002-12-13	2004-07-08	Izumi Tile Carpet Kk	複合超微粒子触媒と、それを含有する組成物と、それらを加えた材料
CN100502976C (zh) *	2003-08-15	2009-06-24	建铭生活国际股份有限公司	光波磁能抗菌结合的保健品的制造方法
CN1519014A (zh) *	2003-09-03	2004-08-11	上海弘康科技发展有限公司	一种多功能活血镇定膏及其制备方法

2005
- 2005-11-03 CN CN2005101172699A patent/CN1957946B/zh not_active Expired - Fee Related
- 2005-11-23 CA CA2529239A patent/CA2529239C/en not_active Expired - Fee Related
2006
- 2006-03-16 KR KR1020087010112A patent/KR100961595B1/ko not_active Expired - Fee Related
- 2006-03-16 AT AT06705333T patent/ATE537805T1/de active
- 2006-03-16 JP JP2008538231A patent/JP5015165B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE537805T1 (de)	2012-01-15
JP5015165B2 (ja)	2012-08-29
CN1957946B (zh)	2010-08-11
CN1957946A (zh)	2007-05-09
JP2009514570A (ja)	2009-04-09
KR100961595B1 (ko)	2010-06-04
KR20080065626A (ko)	2008-07-14
CA2529239A1 (en)	2007-05-03

Legal Events

Date	Code	Title	Description
2008-04-25	EEER	Examination request
2023-07-05	MKLA	Lapsed	Effective date: 20211123

Publication	Publication Date	Title
CN103271894B (zh)	2014-12-17	一种行气活血消肿散结远红外磁疗贴
CN101810844B (zh)	2012-06-13	一种治未病的外用贴膏及其制作方法
CN1939491A (zh)	2007-04-04	一种治疗骨刺的中草药及其制备方法
CA2529239C (en)	2011-03-08	Non-invasive acupuncture device
Anushiravani et al.	2019	Comparing effectiveness of a combined herbal drug based on Echium amoenum with Citalopram in the treatment of Major Depressive Disorder
CN102078391A (zh)	2011-06-01	一种治疗颈肩腰腿疼痛的药物
WO2007118430A1 (fr)	2007-10-25	Matière composite fonctionnelle possédant un bon effet thérapeutique, et préparation et utilisations de celle-ci
US8936815B2 (en)	2015-01-20	Device for external use in alternative medicine applications
CN104258344B (zh)	2017-06-27	温中固本穴位贴膏及其制备方法
CN104224529A (zh)	2014-12-24	艾叶妇科保健贴
RU2139069C1 (ru)	1999-10-10	Средство для лечения патологических состояний "астромеланин"/"астронэлла")
CN1709445A (zh)	2005-12-21	一种主治急慢性扭挫伤、风湿、类风湿疾病的藏药药物及其制备方法
Ma	2009	Acupuncture as a complementary therapy in chemotherapy-induced nausea and vomiting
CN114848789B (zh)	2023-04-25	一种止痛麦粒灸的介质及其制备方法
CN105434467A (zh)	2016-03-30	一种冻疮治疗剂及其生产方法
Ou et al.	2014	A primitive approach to Ou MC decrescendo phenomenon with a hands-on therapy--The relation between human bilateral symmetry and disease
CN100998823A (zh)	2007-07-18	一种治疗骨质增生、腰椎间盘突出症的膏药
CN104784627A (zh)	2015-07-22	一种用于治疗外科开放性或闭合性损伤的中药外用膜剂及其制备方法
CN110327441A (zh)	2019-10-15	一种直接作用于体表的中药线香及制备方法
CN102309526A (zh)	2012-01-11	一种治疗烧烫伤的中药软膏剂及其加工方法
CN100333774C (zh)	2007-08-29	一种治疗腰椎间盘突出症的膏药
Zhang et al.	2013	Clinical observation on acupuncture treatment for cerebral infarction sequela
He et al.	2017	Efficacy of topical administration of Radix Euphorbiae Ebracteolatae on multiple plantar warts: A parallel randomized trial
Husain	2020	Homeopathy in Practice: Clinical Insights Into Homeopathy & Remedies
Lamina et al.	2008	Shortwave diathermy in the management of chronic pelvic inflammatory disease pain